Background: Dyslipidemia and hypertension are the leading causes of morbidity and mortality in patients with cardiovascular diseases (CVDs).
Objective: The study sought to evaluate the effects of -fortified bread on metabolic risk factors among CVD outpatients.
Method: From August 2016 to April 2017, a pilot study using a single-blinded randomized placebo-controlled trial was conducted by administering -fortified bread (150 g) and indistinguishable placebo (150 g white flour bread) daily to 122 CVD outpatients at 37 Military Hospital, Accra, Ghana, for 90 days.